LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Fennec Intends To Engage In Non-brokered Offering Of Common Shares In Canada At $7.50/Shr 11/13/2025 11:31:56 PM
  • Fennec Pharma Q3 Loss/share $0.02 Vs. Loss $0.21 Year Ago 11/13/2025 4:11:34 PM
  • Fennec Pharmaceuticals Q2 Net Loss/shr $0.11 Vs. Loss/shr $0.20 Last Year 8/14/2025 6:13:50 AM
  • Fennec Pharma Q1 Total Net Revenues $8.8 Mln, Up 18% Year Over Year 5/13/2025 6:07:56 AM
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) FY25 Rev. Estimate To 62.3 M From 65.8 M 3/10/2025 8:58:52 PM
  • Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q4 25 Rev. Estimate To 25.0 M From 25.6 M 3/10/2025 8:58:40 PM
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) Q3 25 Rev. Estimate To 21.4 M From 22.2 M 3/10/2025 8:58:30 PM
  • Wedbush Is Lowering Fennec Pharmaceuticals Inc (FENC) Q2 25 Rev. Estimate To 8.4 M From 9.7 M 3/10/2025 8:58:19 PM
  • Wedbush Is Cutting Fennec Pharmaceuticals Inc (FENC) Q1 25 Rev. Estimate To 7.6 M From 8.4 M 3/10/2025 8:58:08 PM
  • Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) FY25 Estimate To 0.55 From 0.40 3/10/2025 8:57:41 PM
  • Wedbush Is Increasing Fennec Pharmaceuticals Inc (FENC) Q4 25 Estimate To 0.42 From 0.37 3/10/2025 8:57:29 PM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap